middle.news
Entropy Neurodynamics Completes First Cohort Dosing in Binge Eating Disorder Trial
8:56am on Tuesday 2nd of June, 2026 AEST
•
Biotechnology
Read Story
Entropy Neurodynamics Completes First Cohort Dosing in Binge Eating Disorder Trial
8:56am on Tuesday 2nd of June, 2026 AEST
Key Points
Completed dosing in first cohort of Phase 2 BED trial
IV-infused psilocin showed controlled, reproducible psychedelic effects
Second cohort dosing pending DSMB review
Topline results expected July 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE